Don't want ads? Subscribe or login now.

EU Court Adviser Sides With German Drugmaker In VAT Fight

By Vidya Kauri · July 13, 2017, 5:54 PM EDT

German drugmakers may be able to include price rebates while calculating value-added tax on sales to private health insurers, just as they can for public health insurance funds, after a European...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Vidya

June 21, 2019
Private Cos. Face Higher Costs In Tax Disclosure Proposals
June 18, 2019
IRS Aims To Fix Error Slanting Farm Sales Toward Co-Ops
June 14, 2019
A New Tax Strategy For Multinationals: Shunning Tax Havens
June 11, 2019
No Tax On $4M Gain For Greek Mining Co., DC Circ. Affirms
June 07, 2019
9th Circ. Again Revives IRS Cost-Sharing Rule In Altera Row
May 24, 2019
DC Circ. Denies $33M Deduction For Land Gift To U Of Mich.
May 22, 2019
Executive Privilege A Poor Shield For Trump's Tax Docs
May 17, 2019
High Court Plea Could Undermine Tax Laws Lacking Regs
May 15, 2019
10th Circ. Denies Deductions For Benefit Plan Expenses
May 13, 2019
Attys Back Biz Owner's High Court Plea To Refuse Subpoenas

EU Court Adviser Sides With German Drugmaker In VAT Fight

Related Sections

Recent Articles By Vidya